Regeneron (REGN) Announces Dupixent is Now Approved in European Union for Severe Chronic Rhinosinusitis with Nasal Polyposis

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/9/2026

1. BRZE
2. TTAN
3. AAPL
4. CHYM
5. USO
6. QCOM
7. IRT
8. ASO
9. LAES
10. NTHI

Go back to Regeneron (REGN) Announces Dupixent is Now Approved in European Union for Severe Chronic Rhinosinusitis with Nasal Polyposis
Regeneron (NASDAQ: REGN) Delayed: 807.08 -3.23 (0.4%)
Previous Close $810.31    52 Week High $592.36 
Open $803.83    52 Week Low $325.35 
Day High $808.63    P/E 211.83 
Day Low $796.73    EPS $3.81 
Volume 239,645       

SANOFI (NASDAQ: SNY) Delayed: 42.99 -0.16 (0.37%)
Previous Close $43.15    52 Week High $44.76 
Open $43.08    52 Week Low $36.81 
Day High $43.46    P/E N/A 
Day Low $42.95    EPS $0.00 
Volume 982,549